Vendor Financing Arrangement |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Vendor Financing Arrangement | |
| Vendor Financing Arrangement | 13. Vendor Financing Arrangement The Company and IQVIA, Inc. (“IQVIA”) entered into a master services agreement (“IQVIA Master Services Agreement”) for the Company’s strategic collaboration with IQVIA to leverage IQVIA’s infrastructure and established commercialization solutions to complement the Company’s launch strategy for AVMAPKI FAKZYNJA CO-PACK in patients with KRAS mutant recurrent LGSOC. Pursuant to the IQVIA Master Services Agreement, the Company has extended payment terms with respect to a portion of the services provided and has recorded a vendor financing arrangement liability of $7.7 million and $10.3 million as of June 30, 2026 and December 31, 2025, respectively. The Company expects to pay the amounts recorded as liabilities during 2026 and 2027. |